| 0 |
NPM1 GENE MUTATION |
11 |
0.7857 |
| 1 |
PROTOTHECOSIS |
34 |
0.3617 |
| 2 |
PSEUDOALDOSTERONISM |
64 |
0.3232 |
| 3 |
MICROSPORUM INFECTION |
8 |
0.2500 |
| 4 |
LEFT ATRIAL HYPERTROPHY |
11 |
0.2200 |
| 5 |
DEMODICIDOSIS |
19 |
0.2065 |
| 6 |
ACANTHAMOEBA KERATITIS |
7 |
0.1892 |
| 7 |
FUSARIUM INFECTION |
105 |
0.1500 |
| 8 |
TERTIARY ADRENAL INSUFFICIENCY |
8 |
0.1481 |
| 9 |
MICROSPORIDIA INFECTION |
50 |
0.1425 |
| 10 |
GEOTRICHUM INFECTION |
29 |
0.1374 |
| 11 |
ADENOVIRUS REACTIVATION |
19 |
0.1319 |
| 12 |
CHIMERISM |
11 |
0.1236 |
| 13 |
ACANTHAMOEBA INFECTION |
23 |
0.1223 |
| 14 |
APPARENT MINERALOCORTICOID EXCESS |
7 |
0.1207 |
| 15 |
CEREBRAL VENTRICLE COLLAPSE |
9 |
0.1200 |
| 16 |
ACQUIRED APPARENT MINERALOCORTICOID EXCESS |
7 |
0.1129 |
| 17 |
SCEDOSPORIUM INFECTION |
79 |
0.1119 |
| 18 |
ENCEPHALITIS FUNGAL |
10 |
0.1111 |
| 19 |
DISSEMINATED TOXOPLASMOSIS |
13 |
0.1083 |
| 20 |
CORTICAL VISUAL IMPAIRMENT |
6 |
0.1034 |
| 21 |
BRONCHIOLITIS OBLITERANS SYNDROME |
18 |
0.1029 |
| 22 |
ALLOGENIC STEM CELL TRANSPLANTATION |
16 |
0.1013 |
| 23 |
CORYNEBACTERIUM BACTERAEMIA |
8 |
0.0941 |
| 24 |
BK POLYOMAVIRUS TEST POSITIVE |
9 |
0.0938 |
| 25 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
21 |
0.0905 |
| 26 |
OVERGROWTH FUNGAL |
9 |
0.0874 |
| 27 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
14 |
0.0809 |
| 28 |
BORDETELLA INFECTION |
7 |
0.0778 |
| 29 |
DIFFERENTIATION SYNDROME |
57 |
0.0777 |
| 30 |
EYE INFECTION FUNGAL |
28 |
0.0724 |
| 31 |
DISSEMINATED COCCIDIOIDOMYCOSIS |
10 |
0.0709 |
| 32 |
PULMONARY MUCORMYCOSIS |
37 |
0.0701 |
| 33 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
12 |
0.0698 |
| 34 |
ADENOVIRAL HEPATITIS |
16 |
0.0681 |
| 35 |
MUCORMYCOSIS |
171 |
0.0657 |
| 36 |
LIP SQUAMOUS CELL CARCINOMA |
11 |
0.0655 |
| 37 |
MYCETOMA MYCOTIC |
9 |
0.0647 |
| 38 |
PHAEOHYPHOMYCOSIS |
31 |
0.0647 |
| 39 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
138 |
0.0642 |
| 40 |
MYCOTIC ENDOPHTHALMITIS |
12 |
0.0635 |
| 41 |
RHINOCEREBRAL MUCORMYCOSIS |
22 |
0.0634 |
| 42 |
HEPATOSPLENIC CANDIDIASIS |
9 |
0.0612 |
| 43 |
QUADRANTANOPIA |
8 |
0.0611 |
| 44 |
CUTANEOUS MUCORMYCOSIS |
11 |
0.0598 |
| 45 |
CHRONIC GRAFT VERSUS HOST DISEASE IN EYE |
12 |
0.0591 |
| 46 |
CEREBRAL ASPERGILLOSIS |
35 |
0.0569 |
| 47 |
PRIMARY ADRENAL INSUFFICIENCY |
17 |
0.0557 |
| 48 |
SYSTEMIC MYCOSIS |
63 |
0.0539 |
| 49 |
NEUTROPHIL PELGER-HUET ANOMALY PRESENT |
10 |
0.0535 |
| 50 |
ELECTROCARDIOGRAM PR SHORTENED |
11 |
0.0524 |
| 51 |
RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS |
7 |
0.0515 |
| 52 |
CONGENITAL APLASIA |
16 |
0.0514 |
| 53 |
ABSCESS FUNGAL |
9 |
0.0514 |
| 54 |
CYSTITIS VIRAL |
19 |
0.0496 |
| 55 |
OSTEOMYELITIS FUNGAL |
8 |
0.0479 |
| 56 |
SKIN MACERATION |
7 |
0.0458 |
| 57 |
DISSEMINATED MUCORMYCOSIS |
17 |
0.0431 |
| 58 |
PNEUMONIA FUNGAL |
166 |
0.0420 |
| 59 |
GASTROINTESTINAL MUCORMYCOSIS |
7 |
0.0419 |
| 60 |
GRAFT VERSUS HOST DISEASE IN LIVER |
30 |
0.0419 |
| 61 |
INTRAOCULAR PRESSURE TEST |
10 |
0.0417 |
| 62 |
SEPTIC ENCEPHALOPATHY |
7 |
0.0407 |
| 63 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
84 |
0.0394 |
| 64 |
HERPES SIMPLEX REACTIVATION |
15 |
0.0394 |
| 65 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
15 |
0.0386 |
| 66 |
ECTHYMA |
15 |
0.0374 |
| 67 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
54 |
0.0373 |
| 68 |
SYSTEMIC CANDIDA |
93 |
0.0370 |
| 69 |
GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION |
10 |
0.0368 |
| 70 |
ZYGOMYCOSIS |
17 |
0.0363 |
| 71 |
SEPTIC EMBOLUS |
30 |
0.0361 |
| 72 |
GRAFT VERSUS HOST DISEASE IN LUNG |
17 |
0.0356 |
| 73 |
CEREBRAL TOXOPLASMOSIS |
33 |
0.0353 |
| 74 |
HERPES SIMPLEX TEST POSITIVE |
7 |
0.0352 |
| 75 |
FUNGAEMIA |
55 |
0.0349 |
| 76 |
ASPERGILLUS INFECTION |
225 |
0.0342 |
| 77 |
GRAFT COMPLICATION |
20 |
0.0341 |
| 78 |
KUSSMAUL RESPIRATION |
7 |
0.0337 |
| 79 |
GRAFT VERSUS HOST DISEASE IN SKIN |
74 |
0.0336 |
| 80 |
KLEBSIELLA BACTERAEMIA |
31 |
0.0326 |
| 81 |
ASPERGILLUS TEST POSITIVE |
10 |
0.0325 |
| 82 |
PULMONARY RESECTION |
8 |
0.0323 |
| 83 |
UREAPLASMA INFECTION |
13 |
0.0319 |
| 84 |
CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE |
6 |
0.0316 |
| 85 |
GRAFT VERSUS HOST DISEASE IN EYE |
7 |
0.0303 |
| 86 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
133 |
0.0301 |
| 87 |
SINUSITIS FUNGAL |
24 |
0.0299 |
| 88 |
ENTEROBACTER BACTERAEMIA |
9 |
0.0297 |
| 89 |
GRAFT VERSUS HOST DISEASE |
212 |
0.0295 |
| 90 |
VENOUS HAEMORRHAGE |
9 |
0.0290 |
| 91 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
41 |
0.0290 |
| 92 |
ENTEROCOCCAL BACTERAEMIA |
30 |
0.0283 |
| 93 |
DERMATOPHYTOSIS |
8 |
0.0282 |
| 94 |
VIRAL HAEMORRHAGIC CYSTITIS |
20 |
0.0281 |
| 95 |
BRONCHOPULMONARY ASPERGILLOSIS |
213 |
0.0274 |
| 96 |
CHOROIDAL EFFUSION |
22 |
0.0274 |
| 97 |
TISSUE INFILTRATION |
8 |
0.0271 |
| 98 |
CARDIAC VALVE VEGETATION |
13 |
0.0267 |
| 99 |
FUNGAL ENDOCARDITIS |
8 |
0.0266 |
| 100 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
19 |
0.0264 |
| 101 |
GROWTH FAILURE |
9 |
0.0262 |
| 102 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
71 |
0.0257 |
| 103 |
CITROBACTER INFECTION |
11 |
0.0256 |
| 104 |
NECROTISING RETINITIS |
16 |
0.0250 |
| 105 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
9 |
0.0247 |
| 106 |
CHRONIC GRAFT VERSUS HOST DISEASE |
87 |
0.0241 |
| 107 |
HYPERLEUKOCYTOSIS |
21 |
0.0237 |
| 108 |
NEUTROPENIC INFECTION |
22 |
0.0230 |
| 109 |
RETINAL ISCHAEMIA |
14 |
0.0229 |
| 110 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
21 |
0.0227 |
| 111 |
PARAINFLUENZAE VIRUS INFECTION |
33 |
0.0217 |
| 112 |
ENTEROBACTER SEPSIS |
8 |
0.0216 |
| 113 |
STENOTROPHOMONAS INFECTION |
29 |
0.0214 |
| 114 |
BK VIRUS INFECTION |
72 |
0.0213 |
| 115 |
GLUCOCORTICOID DEFICIENCY |
9 |
0.0213 |
| 116 |
RESPIRATORY TRACT INFECTION FUNGAL |
11 |
0.0208 |
| 117 |
IDIOPATHIC PNEUMONIA SYNDROME |
6 |
0.0201 |
| 118 |
BRAIN ABSCESS |
51 |
0.0201 |
| 119 |
BRAIN COMPRESSION |
8 |
0.0200 |
| 120 |
PSEUDOMONAL BACTERAEMIA |
17 |
0.0199 |
| 121 |
KLEBSIELLA SEPSIS |
22 |
0.0195 |
| 122 |
PULMONARY NOCARDIOSIS |
16 |
0.0194 |
| 123 |
MYOPERICARDITIS |
15 |
0.0192 |
| 124 |
POLYMYOSITIS |
34 |
0.0192 |
| 125 |
PLATELET TRANSFUSION |
24 |
0.0186 |
| 126 |
ENTEROCOCCAL INFECTION |
89 |
0.0184 |
| 127 |
MYCOBACTERIUM ABSCESSUS INFECTION |
13 |
0.0182 |
| 128 |
INFECTIVE ANEURYSM |
9 |
0.0182 |
| 129 |
LUNG TRANSPLANT REJECTION |
12 |
0.0182 |
| 130 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
60 |
0.0181 |
| 131 |
ANAEMIA MEGALOBLASTIC |
8 |
0.0179 |
| 132 |
HAEMATOLOGICAL INFECTION |
42 |
0.0172 |
| 133 |
PARTIAL SEIZURES WITH SECONDARY GENERALISATION |
8 |
0.0171 |
| 134 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
11 |
0.0168 |
| 135 |
CARDIOACTIVE DRUG LEVEL INCREASED |
22 |
0.0167 |
| 136 |
PSEUDOMONAL SEPSIS |
29 |
0.0165 |
| 137 |
STAPHYLOCOCCAL BACTERAEMIA |
69 |
0.0159 |
| 138 |
HERPES SIMPLEX ENCEPHALITIS |
7 |
0.0151 |
| 139 |
DISEASE RISK FACTOR |
6 |
0.0149 |
| 140 |
ESCHERICHIA BACTERAEMIA |
35 |
0.0149 |
| 141 |
MINIMAL RESIDUAL DISEASE |
7 |
0.0145 |
| 142 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
19 |
0.0144 |
| 143 |
NEUTROPENIC COLITIS |
29 |
0.0140 |
| 144 |
STEROID DIABETES |
21 |
0.0140 |
| 145 |
FEBRILE NEUTROPENIA |
917 |
0.0138 |
| 146 |
MEDIASTINITIS |
8 |
0.0138 |
| 147 |
ACUTE MYELOID LEUKAEMIA |
215 |
0.0138 |
| 148 |
CELLULITIS ORBITAL |
8 |
0.0137 |
| 149 |
LEUKAEMIA RECURRENT |
23 |
0.0136 |
| 150 |
PNEUMONIA KLEBSIELLA |
25 |
0.0136 |
| 151 |
NOCARDIOSIS |
34 |
0.0133 |
| 152 |
HUMAN POLYOMAVIRUS INFECTION |
7 |
0.0132 |
| 153 |
HYPOFIBRINOGENAEMIA |
13 |
0.0131 |
| 154 |
SOFT TISSUE INFECTION |
24 |
0.0131 |
| 155 |
CORYNEBACTERIUM INFECTION |
7 |
0.0131 |
| 156 |
PNEUMONIA PSEUDOMONAL |
20 |
0.0130 |
| 157 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
10 |
0.0130 |
| 158 |
BLOOD IMMUNOGLOBULIN A INCREASED |
7 |
0.0130 |
| 159 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
12 |
0.0130 |
| 160 |
PSEUDOMONAS INFECTION |
111 |
0.0129 |
| 161 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
10 |
0.0127 |
| 162 |
INTRACRANIAL MASS |
12 |
0.0127 |
| 163 |
COCCIDIOIDOMYCOSIS |
15 |
0.0126 |
| 164 |
ADENOVIRUS INFECTION |
36 |
0.0124 |
| 165 |
ENTEROCOCCAL SEPSIS |
10 |
0.0123 |
| 166 |
VENOOCCLUSIVE LIVER DISEASE |
61 |
0.0123 |
| 167 |
CEREBRAL ARTERY EMBOLISM |
15 |
0.0123 |
| 168 |
INFECTION REACTIVATION |
14 |
0.0122 |
| 169 |
ENGRAFTMENT SYNDROME |
7 |
0.0118 |
| 170 |
BACTERAEMIA |
138 |
0.0116 |
| 171 |
METAPNEUMOVIRUS INFECTION |
9 |
0.0115 |
| 172 |
CRYPTOSPORIDIOSIS INFECTION |
6 |
0.0114 |
| 173 |
BLOOD IMMUNOGLOBULIN G DECREASED |
28 |
0.0113 |
| 174 |
NEPHROGENIC DIABETES INSIPIDUS |
13 |
0.0113 |
| 175 |
CYTOPENIA |
138 |
0.0113 |
| 176 |
CANDIDA SEPSIS |
10 |
0.0111 |
| 177 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
66 |
0.0111 |
| 178 |
FUNGAL SEPSIS |
9 |
0.0108 |
| 179 |
EPSTEIN-BARR VIRAEMIA |
12 |
0.0108 |
| 180 |
KLEBSIELLA INFECTION |
54 |
0.0107 |
| 181 |
CENTRAL NERVOUS SYSTEM INFECTION |
12 |
0.0105 |
| 182 |
SINUSITIS BACTERIAL |
11 |
0.0104 |
| 183 |
CYTOMEGALOVIRUS VIRAEMIA |
46 |
0.0103 |
| 184 |
HYPERBILIRUBINAEMIA |
105 |
0.0101 |
| 185 |
ESCHERICHIA SEPSIS |
29 |
0.0100 |
| 186 |
TUMOUR LYSIS SYNDROME |
88 |
0.0100 |
| 187 |
ASPERGILLOSIS |
13 |
0.0099 |
| 188 |
MUSCLE NECROSIS |
9 |
0.0099 |
| 189 |
HYPOGONADISM |
10 |
0.0099 |
| 190 |
BILIRUBIN CONJUGATED INCREASED |
23 |
0.0098 |
| 191 |
ACUTE GRAFT VERSUS HOST DISEASE |
45 |
0.0098 |
| 192 |
MYOSITIS |
88 |
0.0098 |
| 193 |
BRAIN HERNIATION |
29 |
0.0097 |
| 194 |
ARTHRITIS REACTIVE |
6 |
0.0096 |
| 195 |
HEPATIC CYTOLYSIS |
121 |
0.0095 |
| 196 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
14 |
0.0093 |
| 197 |
PATHOGEN RESISTANCE |
84 |
0.0092 |
| 198 |
BACTERIAL SEPSIS |
30 |
0.0092 |
| 199 |
INFECTIOUS PLEURAL EFFUSION |
14 |
0.0092 |
| 200 |
STAPHYLOCOCCAL SEPSIS |
45 |
0.0091 |
| 201 |
PULMONARY MYCOSIS |
7 |
0.0090 |
| 202 |
PULMONARY SEPSIS |
13 |
0.0089 |
| 203 |
EXTREMITY NECROSIS |
15 |
0.0086 |
| 204 |
LUNG CONSOLIDATION |
24 |
0.0086 |
| 205 |
FEBRILE INFECTION |
10 |
0.0085 |
| 206 |
SEPTIC SHOCK |
368 |
0.0084 |
| 207 |
BONE MARROW TRANSPLANT |
16 |
0.0084 |
| 208 |
ADRENAL SUPPRESSION |
7 |
0.0083 |
| 209 |
STREPTOCOCCAL BACTERAEMIA |
9 |
0.0083 |
| 210 |
BACTERIAL DISEASE CARRIER |
6 |
0.0082 |
| 211 |
ENCEPHALITIS VIRAL |
10 |
0.0082 |
| 212 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
21 |
0.0081 |
| 213 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
61 |
0.0081 |
| 214 |
TRANSPLANT |
19 |
0.0080 |
| 215 |
LUNG OPACITY |
21 |
0.0080 |
| 216 |
LONG QT SYNDROME |
19 |
0.0079 |
| 217 |
JUGULAR VEIN THROMBOSIS |
14 |
0.0079 |
| 218 |
ANGLE CLOSURE GLAUCOMA |
20 |
0.0078 |
| 219 |
DEBRIDEMENT |
6 |
0.0078 |
| 220 |
DRUG LEVEL BELOW THERAPEUTIC |
43 |
0.0078 |
| 221 |
METHAEMOGLOBINAEMIA |
18 |
0.0078 |
| 222 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
22 |
0.0078 |
| 223 |
ENTEROBACTER INFECTION |
13 |
0.0077 |
| 224 |
HEPATIC NECROSIS |
29 |
0.0077 |
| 225 |
ATYPICAL PNEUMONIA |
23 |
0.0077 |
| 226 |
BLAST CELL COUNT INCREASED |
8 |
0.0076 |
| 227 |
ILEUS PARALYTIC |
34 |
0.0076 |
| 228 |
BONE MARROW TOXICITY |
9 |
0.0076 |
| 229 |
OPTIC NEUROPATHY |
16 |
0.0076 |
| 230 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
7 |
0.0076 |
| 231 |
HERPES SIMPLEX |
49 |
0.0075 |
| 232 |
DEVICE RELATED INFECTION |
116 |
0.0075 |
| 233 |
LEUKOENCEPHALOPATHY |
28 |
0.0075 |
| 234 |
PLASMA CELL MYELOMA REFRACTORY |
10 |
0.0075 |
| 235 |
CYSTITIS HAEMORRHAGIC |
30 |
0.0074 |
| 236 |
CYTOKINE RELEASE SYNDROME |
149 |
0.0074 |
| 237 |
DRUG RESISTANCE |
190 |
0.0074 |
| 238 |
CYTOMEGALOVIRUS TEST POSITIVE |
13 |
0.0073 |
| 239 |
PNEUMONIA CYTOMEGALOVIRAL |
14 |
0.0072 |
| 240 |
CROSS SENSITIVITY REACTION |
7 |
0.0072 |
| 241 |
NEUTROPENIC SEPSIS |
51 |
0.0071 |
| 242 |
DUODENAL PERFORATION |
7 |
0.0071 |
| 243 |
MUCOSAL DISORDER |
7 |
0.0070 |
| 244 |
HYPOGAMMAGLOBULINAEMIA |
46 |
0.0070 |
| 245 |
CYTOMEGALOVIRUS INFECTION |
116 |
0.0070 |
| 246 |
THROMBOTIC MICROANGIOPATHY |
68 |
0.0070 |
| 247 |
NEPHROPATHY TOXIC |
78 |
0.0069 |
| 248 |
DEMYELINATING POLYNEUROPATHY |
7 |
0.0068 |
| 249 |
RHINOVIRUS INFECTION |
26 |
0.0067 |
| 250 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
186 |
0.0066 |
| 251 |
VASCULAR PURPURA |
9 |
0.0064 |
| 252 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
39 |
0.0064 |
| 253 |
ENTEROCOLITIS |
37 |
0.0064 |
| 254 |
STEM CELL TRANSPLANT |
16 |
0.0064 |
| 255 |
ACINETOBACTER INFECTION |
7 |
0.0064 |
| 256 |
TORSADE DE POINTES |
50 |
0.0064 |
| 257 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
11 |
0.0063 |
| 258 |
CANDIDA INFECTION |
105 |
0.0062 |
| 259 |
FUNGAL SKIN INFECTION |
25 |
0.0062 |
| 260 |
SKIN NECROSIS |
32 |
0.0062 |
| 261 |
APLASTIC ANAEMIA |
32 |
0.0061 |
| 262 |
OBLITERATIVE BRONCHIOLITIS |
8 |
0.0061 |
| 263 |
DRUG LEVEL DECREASED |
62 |
0.0061 |
| 264 |
FUNGAL INFECTION |
202 |
0.0061 |
| 265 |
PACKED RED BLOOD CELL TRANSFUSION |
8 |
0.0060 |
| 266 |
PAROTITIS |
7 |
0.0060 |
| 267 |
GASTRIC DILATATION |
10 |
0.0060 |
| 268 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
13 |
0.0059 |
| 269 |
PANCYTOPENIA |
328 |
0.0059 |
| 270 |
GASTROINTESTINAL TOXICITY |
28 |
0.0058 |
| 271 |
HUMAN HERPESVIRUS 6 INFECTION |
11 |
0.0058 |
| 272 |
CAPILLARY LEAK SYNDROME |
12 |
0.0058 |
| 273 |
GASTROINTESTINAL VIRAL INFECTION |
6 |
0.0058 |
| 274 |
ENDOPHTHALMITIS |
34 |
0.0057 |
| 275 |
CYTOMEGALOVIRUS COLITIS |
13 |
0.0056 |
| 276 |
JC VIRUS INFECTION |
9 |
0.0056 |
| 277 |
BONE MARROW DISORDER |
17 |
0.0056 |
| 278 |
APLASIA |
11 |
0.0056 |
| 279 |
EPSTEIN-BARR VIRUS INFECTION |
35 |
0.0056 |
| 280 |
DISINHIBITION |
9 |
0.0056 |
| 281 |
BONE NEOPLASM |
6 |
0.0056 |
| 282 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
13 |
0.0055 |
| 283 |
MULTIPLE-DRUG RESISTANCE |
17 |
0.0055 |
| 284 |
DERMATITIS EXFOLIATIVE GENERALISED |
19 |
0.0055 |
| 285 |
NEUROTOXICITY |
94 |
0.0054 |
| 286 |
DRUG INTERACTION |
838 |
0.0053 |
| 287 |
MYCOBACTERIAL INFECTION |
9 |
0.0052 |
| 288 |
HEPATOTOXICITY |
114 |
0.0051 |
| 289 |
CHOLESTASIS |
97 |
0.0050 |
| 290 |
SERUM SICKNESS |
14 |
0.0050 |
| 291 |
ESCHERICHIA TEST POSITIVE |
6 |
0.0050 |
| 292 |
LUNG INFILTRATION |
44 |
0.0050 |
| 293 |
NEUTROPENIA |
675 |
0.0050 |
| 294 |
ORGAN FAILURE |
20 |
0.0050 |
| 295 |
ACUTE LEUKAEMIA |
8 |
0.0050 |
| 296 |
ATYPICAL MYCOBACTERIAL INFECTION |
7 |
0.0049 |
| 297 |
BACTERIAL INFECTION |
92 |
0.0049 |
| 298 |
DRUG LEVEL INCREASED |
81 |
0.0049 |
| 299 |
HYPOMAGNESAEMIA |
68 |
0.0049 |
| 300 |
BONE MARROW FAILURE |
99 |
0.0049 |
| 301 |
HYPOPHOSPHATAEMIA |
36 |
0.0049 |
| 302 |
TRANSPLANT REJECTION |
39 |
0.0049 |
| 303 |
OTOTOXICITY |
9 |
0.0049 |
| 304 |
ELECTROCARDIOGRAM QT PROLONGED |
175 |
0.0049 |
| 305 |
VITRITIS |
9 |
0.0049 |
| 306 |
HYPOKALAEMIA |
224 |
0.0048 |
| 307 |
VARICELLA ZOSTER VIRUS INFECTION |
10 |
0.0048 |
| 308 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
46 |
0.0048 |
| 309 |
ACUTE PULMONARY OEDEMA |
27 |
0.0048 |
| 310 |
CEREBRAL HAEMATOMA |
16 |
0.0048 |
| 311 |
NEUROLOGICAL DECOMPENSATION |
11 |
0.0047 |
| 312 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
41 |
0.0047 |
| 313 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
48 |
0.0047 |
| 314 |
STUPOR |
15 |
0.0047 |
| 315 |
MIXED LIVER INJURY |
14 |
0.0046 |
| 316 |
LYMPHOPENIA |
65 |
0.0046 |
| 317 |
DRUG LEVEL ABOVE THERAPEUTIC |
21 |
0.0046 |
| 318 |
CELL DEATH |
9 |
0.0045 |
| 319 |
ESCHERICHIA INFECTION |
37 |
0.0045 |
| 320 |
TRANSPLANT FAILURE |
11 |
0.0045 |
| 321 |
ENCEPHALOPATHY |
110 |
0.0045 |
| 322 |
DEVICE RELATED SEPSIS |
9 |
0.0045 |
| 323 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
12 |
0.0045 |
| 324 |
HISTOPLASMOSIS DISSEMINATED |
7 |
0.0044 |
| 325 |
HOSPICE CARE |
43 |
0.0043 |
| 326 |
LUNG ABSCESS |
9 |
0.0043 |
| 327 |
ENDOCARDITIS |
22 |
0.0043 |
| 328 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
13 |
0.0043 |
| 329 |
ORGANISING PNEUMONIA |
21 |
0.0042 |
| 330 |
CATHETER SITE INFECTION |
16 |
0.0042 |
| 331 |
MUCOSAL INFLAMMATION |
110 |
0.0042 |
| 332 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
37 |
0.0042 |
| 333 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
73 |
0.0041 |
| 334 |
CYTOMEGALOVIRUS CHORIORETINITIS |
8 |
0.0041 |
| 335 |
PUPIL FIXED |
7 |
0.0040 |
| 336 |
VASCULAR PSEUDOANEURYSM |
7 |
0.0040 |
| 337 |
VENOOCCLUSIVE DISEASE |
10 |
0.0040 |
| 338 |
CHRONIC GASTRITIS |
9 |
0.0040 |
| 339 |
VASCULAR DEVICE INFECTION |
18 |
0.0040 |
| 340 |
GASTROINTESTINAL OEDEMA |
7 |
0.0040 |
| 341 |
ENTERITIS |
25 |
0.0039 |
| 342 |
THROMBOCYTOPENIA |
434 |
0.0039 |
| 343 |
PARONYCHIA |
17 |
0.0039 |
| 344 |
RASH MACULO-PAPULAR |
86 |
0.0039 |
| 345 |
TONGUE ULCERATION |
13 |
0.0038 |
| 346 |
HEPATITIS TOXIC |
10 |
0.0038 |
| 347 |
ORAL DISORDER |
28 |
0.0038 |
| 348 |
BRAIN OEDEMA |
48 |
0.0038 |
| 349 |
FEBRILE BONE MARROW APLASIA |
16 |
0.0038 |
| 350 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
19 |
0.0037 |
| 351 |
EXOPHTHALMOS |
8 |
0.0037 |
| 352 |
STAPHYLOCOCCAL INFECTION |
122 |
0.0037 |
| 353 |
NEUROLOGICAL SYMPTOM |
21 |
0.0037 |
| 354 |
SERUM FERRITIN INCREASED |
19 |
0.0036 |
| 355 |
POTENTIATING DRUG INTERACTION |
12 |
0.0036 |
| 356 |
RENAL TUBULAR DISORDER |
10 |
0.0036 |
| 357 |
VITAMIN B12 DECREASED |
10 |
0.0035 |
| 358 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
8 |
0.0034 |
| 359 |
CUSHINGOID |
11 |
0.0034 |
| 360 |
IMMUNOSUPPRESSION |
30 |
0.0034 |
| 361 |
CLOSTRIDIUM DIFFICILE COLITIS |
36 |
0.0034 |
| 362 |
LIVER ABSCESS |
11 |
0.0034 |
| 363 |
LEUKAEMIA |
32 |
0.0034 |
| 364 |
HYPOXIA |
119 |
0.0034 |
| 365 |
PNEUMONIA BACTERIAL |
31 |
0.0034 |
| 366 |
MYELOSUPPRESSION |
121 |
0.0034 |
| 367 |
METABOLIC ENCEPHALOPATHY |
10 |
0.0033 |
| 368 |
RENAL TUBULAR NECROSIS |
32 |
0.0033 |
| 369 |
RESPIRATORY FAILURE |
237 |
0.0032 |
| 370 |
TRANSFUSION |
34 |
0.0032 |
| 371 |
RETINAL HAEMORRHAGE |
23 |
0.0032 |
| 372 |
PERICARDIAL EFFUSION |
74 |
0.0032 |
| 373 |
ELECTROLYTE IMBALANCE |
37 |
0.0032 |
| 374 |
GASTROINTESTINAL ULCER |
7 |
0.0032 |
| 375 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
12 |
0.0031 |
| 376 |
RED CELL DISTRIBUTION WIDTH INCREASED |
13 |
0.0031 |
| 377 |
PULMONARY HAEMORRHAGE |
24 |
0.0031 |
| 378 |
MALABSORPTION |
16 |
0.0031 |
| 379 |
GENE MUTATION |
6 |
0.0030 |
| 380 |
PULMONARY ALVEOLAR HAEMORRHAGE |
17 |
0.0030 |
| 381 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
48 |
0.0030 |
| 382 |
SCLERODERMA |
11 |
0.0030 |
| 383 |
CYTOLYTIC HEPATITIS |
10 |
0.0030 |
| 384 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
8 |
0.0030 |
| 385 |
RESPIRATORY TRACT INFECTION VIRAL |
7 |
0.0030 |
| 386 |
CHOLECYSTITIS ACUTE |
17 |
0.0030 |
| 387 |
AREFLEXIA |
8 |
0.0030 |
| 388 |
HEPATITIS CHOLESTATIC |
18 |
0.0030 |
| 389 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
30 |
0.0030 |
| 390 |
PAPULE |
21 |
0.0030 |
| 391 |
AMYLASE INCREASED |
11 |
0.0030 |
| 392 |
CARDIAC DYSFUNCTION |
11 |
0.0030 |
| 393 |
BRONCHOPNEUMONIA |
10 |
0.0029 |
| 394 |
DIASTOLIC DYSFUNCTION |
9 |
0.0029 |
| 395 |
AGRANULOCYTOSIS |
54 |
0.0029 |
| 396 |
BLOOD CREATININE ABNORMAL |
10 |
0.0029 |
| 397 |
ENCEPHALITIS |
20 |
0.0029 |
| 398 |
BLOOD BILIRUBIN INCREASED |
77 |
0.0028 |
| 399 |
HEPATOMEGALY |
28 |
0.0028 |
| 400 |
IRIDOCYCLITIS |
9 |
0.0028 |
| 401 |
HYPERVOLAEMIA |
14 |
0.0028 |
| 402 |
LUNG TRANSPLANT |
10 |
0.0028 |
| 403 |
HYPERAMMONAEMIA |
14 |
0.0028 |
| 404 |
SEPSIS |
310 |
0.0028 |
| 405 |
MULTI-ORGAN FAILURE |
48 |
0.0028 |
| 406 |
DISSEMINATED INTRAVASCULAR COAGULATION |
39 |
0.0028 |
| 407 |
HAEMODYNAMIC INSTABILITY |
21 |
0.0028 |
| 408 |
OLIGURIA |
17 |
0.0027 |
| 409 |
BLOOD PHOSPHORUS DECREASED |
10 |
0.0027 |
| 410 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
6 |
0.0027 |
| 411 |
CARDIAC FAILURE ACUTE |
18 |
0.0027 |
| 412 |
HYPOALBUMINAEMIA |
21 |
0.0027 |
| 413 |
ACTINIC KERATOSIS |
7 |
0.0027 |
| 414 |
NECROSIS |
15 |
0.0027 |
| 415 |
CHOLESTATIC LIVER INJURY |
6 |
0.0027 |
| 416 |
PERIPHERAL VENOUS DISEASE |
11 |
0.0027 |
| 417 |
SINUS BRADYCARDIA |
26 |
0.0027 |
| 418 |
PULMONARY MASS |
40 |
0.0027 |
| 419 |
TRANSAMINASES INCREASED |
59 |
0.0027 |
| 420 |
SQUAMOUS CELL CARCINOMA OF SKIN |
16 |
0.0026 |
| 421 |
BLOOD POTASSIUM ABNORMAL |
7 |
0.0026 |
| 422 |
ABDOMINAL TENDERNESS |
13 |
0.0026 |
| 423 |
HYPERLACTACIDAEMIA |
7 |
0.0026 |
| 424 |
ACUTE RESPIRATORY FAILURE |
50 |
0.0026 |
| 425 |
ANAL ABSCESS |
14 |
0.0026 |
| 426 |
SKIN INFECTION |
29 |
0.0026 |
| 427 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
64 |
0.0026 |
| 428 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
14 |
0.0026 |
| 429 |
HEPATIC FAILURE |
77 |
0.0026 |
| 430 |
HEPATIC LESION |
11 |
0.0025 |
| 431 |
PRODUCT USE IN UNAPPROVED INDICATION |
629 |
0.0025 |
| 432 |
NEUTROPHIL COUNT DECREASED |
103 |
0.0025 |
| 433 |
FAILURE TO THRIVE |
13 |
0.0025 |
| 434 |
ENDOTRACHEAL INTUBATION |
7 |
0.0025 |
| 435 |
LEUKOCYTOSIS |
45 |
0.0025 |
| 436 |
NEUTROPHIL COUNT ABNORMAL |
7 |
0.0025 |
| 437 |
CENTRAL NERVOUS SYSTEM LESION |
34 |
0.0025 |
| 438 |
HYPOVENTILATION |
8 |
0.0025 |
| 439 |
HYPERTRANSAMINASAEMIA |
17 |
0.0024 |
| 440 |
DRUG-INDUCED LIVER INJURY |
76 |
0.0024 |
| 441 |
DISEASE PROGRESSION |
285 |
0.0024 |
| 442 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
12 |
0.0024 |
| 443 |
BLOOD ALBUMIN DECREASED |
19 |
0.0024 |
| 444 |
PULSELESS ELECTRICAL ACTIVITY |
10 |
0.0024 |
| 445 |
PROTEIN TOTAL DECREASED |
9 |
0.0024 |
| 446 |
HYPERPYREXIA |
10 |
0.0024 |
| 447 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
129 |
0.0023 |
| 448 |
PURULENT DISCHARGE |
10 |
0.0023 |
| 449 |
HEPATOSPLENOMEGALY |
6 |
0.0023 |
| 450 |
PROCTALGIA |
15 |
0.0023 |
| 451 |
HEPATOCELLULAR INJURY |
33 |
0.0023 |
| 452 |
APLASIA PURE RED CELL |
8 |
0.0023 |
| 453 |
ACUTE KIDNEY INJURY |
350 |
0.0023 |
| 454 |
COVID-19 PNEUMONIA |
27 |
0.0023 |
| 455 |
CATATONIA |
12 |
0.0023 |
| 456 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
7 |
0.0023 |
| 457 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
8 |
0.0023 |
| 458 |
PLEURAL EFFUSION |
138 |
0.0023 |
| 459 |
JAUNDICE CHOLESTATIC |
8 |
0.0023 |
| 460 |
MALNUTRITION |
25 |
0.0022 |
| 461 |
VASCULITIS |
26 |
0.0022 |
| 462 |
ADRENAL INSUFFICIENCY |
27 |
0.0022 |
| 463 |
MYELODYSPLASTIC SYNDROME |
32 |
0.0022 |
| 464 |
HYPERNATRAEMIA |
11 |
0.0022 |
| 465 |
HEPATIC ENZYME ABNORMAL |
11 |
0.0022 |
| 466 |
ILEUS |
27 |
0.0022 |
| 467 |
TOXIC ENCEPHALOPATHY |
11 |
0.0022 |
| 468 |
LARGE INTESTINE PERFORATION |
15 |
0.0022 |
| 469 |
HALLUCINATIONS, MIXED |
9 |
0.0021 |
| 470 |
CACHEXIA |
11 |
0.0021 |
| 471 |
FULL BLOOD COUNT DECREASED |
43 |
0.0021 |
| 472 |
PLATELET COUNT DECREASED |
226 |
0.0021 |
| 473 |
ABSCESS LIMB |
9 |
0.0021 |
| 474 |
CARDIAC TAMPONADE |
10 |
0.0021 |
| 475 |
RESPIRATORY DISTRESS |
58 |
0.0021 |
| 476 |
DUODENAL ULCER HAEMORRHAGE |
6 |
0.0021 |
| 477 |
SHOCK HAEMORRHAGIC |
17 |
0.0021 |
| 478 |
PERIPHERAL SENSORY NEUROPATHY |
12 |
0.0021 |
| 479 |
MENTAL STATUS CHANGES |
56 |
0.0020 |
| 480 |
BLOOD CULTURE POSITIVE |
6 |
0.0020 |
| 481 |
EJECTION FRACTION DECREASED |
31 |
0.0020 |
| 482 |
SUSPECTED OFF LABEL USE |
9 |
0.0020 |
| 483 |
EMBOLIC STROKE |
7 |
0.0020 |
| 484 |
PLATELET COUNT ABNORMAL |
12 |
0.0020 |
| 485 |
VENTRICULAR FIBRILLATION |
22 |
0.0020 |
| 486 |
PYREXIA |
679 |
0.0020 |
| 487 |
SUBDURAL HAEMATOMA |
28 |
0.0020 |
| 488 |
IMMUNODEFICIENCY |
29 |
0.0019 |
| 489 |
MONOCYTE COUNT INCREASED |
7 |
0.0019 |
| 490 |
PERIORBITAL OEDEMA |
10 |
0.0019 |
| 491 |
RED BLOOD CELL COUNT DECREASED |
55 |
0.0019 |
| 492 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
14 |
0.0019 |
| 493 |
FULL BLOOD COUNT ABNORMAL |
20 |
0.0019 |
| 494 |
HEPATIC PAIN |
8 |
0.0019 |
| 495 |
ATELECTASIS |
18 |
0.0019 |
| 496 |
ANURIA |
16 |
0.0019 |
| 497 |
GENERALISED OEDEMA |
23 |
0.0019 |
| 498 |
BRAIN FOG |
29 |
0.0018 |
| 499 |
TREATMENT FAILURE |
153 |
0.0018 |
| 500 |
DECUBITUS ULCER |
15 |
0.0018 |
| 501 |
PULMONARY FUNCTION TEST DECREASED |
8 |
0.0018 |
| 502 |
ASPIRATION |
20 |
0.0018 |
| 503 |
ORAL CANDIDIASIS |
24 |
0.0018 |
| 504 |
INFLAMMATORY MARKER INCREASED |
9 |
0.0018 |
| 505 |
CELLULITIS |
91 |
0.0018 |
| 506 |
ASCITES |
53 |
0.0018 |
| 507 |
LUNG INFECTION |
28 |
0.0018 |
| 508 |
MENINGITIS |
12 |
0.0018 |
| 509 |
HAEMOPTYSIS |
50 |
0.0018 |
| 510 |
HAEMATOTOXICITY |
17 |
0.0018 |
| 511 |
GASTROINTESTINAL INFECTION |
16 |
0.0018 |
| 512 |
RESPIRATORY ACIDOSIS |
7 |
0.0018 |
| 513 |
AZOTAEMIA |
7 |
0.0018 |
| 514 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
45 |
0.0017 |
| 515 |
IMMUNE THROMBOCYTOPENIA |
8 |
0.0017 |
| 516 |
SKIN PAPILLOMA |
7 |
0.0017 |
| 517 |
MYOPATHY |
15 |
0.0017 |
| 518 |
HYDRONEPHROSIS |
13 |
0.0017 |
| 519 |
BLOOD URIC ACID INCREASED |
10 |
0.0017 |
| 520 |
OBSTRUCTIVE AIRWAYS DISORDER |
19 |
0.0017 |
| 521 |
SPLENOMEGALY |
20 |
0.0017 |
| 522 |
ARTHRITIS BACTERIAL |
7 |
0.0017 |
| 523 |
CARDIOMYOPATHY |
25 |
0.0017 |
| 524 |
NODULE |
22 |
0.0017 |
| 525 |
HAEMOLYSIS |
13 |
0.0017 |
| 526 |
COAGULOPATHY |
28 |
0.0017 |
| 527 |
SUBCUTANEOUS ABSCESS |
8 |
0.0017 |
| 528 |
RENAL IMPAIRMENT |
140 |
0.0017 |
| 529 |
CLOSTRIDIUM DIFFICILE INFECTION |
36 |
0.0016 |
| 530 |
HYPONATRAEMIA |
92 |
0.0016 |
| 531 |
SQUAMOUS CELL CARCINOMA |
15 |
0.0016 |
| 532 |
TOXIC EPIDERMAL NECROLYSIS |
24 |
0.0016 |
| 533 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
8 |
0.0016 |
| 534 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
13 |
0.0016 |
| 535 |
INFECTION |
228 |
0.0016 |
| 536 |
CONJUNCTIVAL HAEMORRHAGE |
6 |
0.0016 |
| 537 |
SKIN LESION |
43 |
0.0016 |
| 538 |
ABSCESS |
25 |
0.0016 |
| 539 |
C-REACTIVE PROTEIN INCREASED |
57 |
0.0016 |
| 540 |
HAEMATOCRIT DECREASED |
31 |
0.0016 |
| 541 |
LEUKOPENIA |
78 |
0.0016 |
| 542 |
DIFFUSE LARGE B-CELL LYMPHOMA |
12 |
0.0016 |
| 543 |
HEPATIC FUNCTION ABNORMAL |
58 |
0.0016 |
| 544 |
PNEUMONIA |
501 |
0.0015 |
| 545 |
TACHYPNOEA |
21 |
0.0015 |
| 546 |
CARDIOPULMONARY FAILURE |
6 |
0.0015 |
| 547 |
HYPERTRIGLYCERIDAEMIA |
9 |
0.0015 |
| 548 |
ORAL HERPES |
30 |
0.0015 |
| 549 |
FOLLICULITIS |
16 |
0.0015 |
| 550 |
HALLUCINATION, VISUAL |
32 |
0.0015 |
| 551 |
CORONAVIRUS INFECTION |
10 |
0.0015 |
| 552 |
CANDIDIASIS |
6 |
0.0015 |
| 553 |
TOXIC SKIN ERUPTION |
15 |
0.0015 |
| 554 |
HYPOPHAGIA |
38 |
0.0015 |
| 555 |
MYOCARDITIS |
17 |
0.0015 |
| 556 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
7 |
0.0015 |
| 557 |
PURPURA |
13 |
0.0015 |
| 558 |
HYDROCEPHALUS |
8 |
0.0015 |
| 559 |
RESPIRATORY TRACT INFECTION |
38 |
0.0015 |
| 560 |
VENTRICULAR TACHYCARDIA |
24 |
0.0015 |
| 561 |
PHOTOSENSITIVITY REACTION |
24 |
0.0015 |
| 562 |
COLITIS |
55 |
0.0014 |
| 563 |
LIVER FUNCTION TEST ABNORMAL |
42 |
0.0014 |
| 564 |
ACIDOSIS |
11 |
0.0014 |
| 565 |
OFF LABEL USE |
1260 |
0.0014 |
| 566 |
LIPASE INCREASED |
11 |
0.0014 |
| 567 |
ALANINE AMINOTRANSFERASE INCREASED |
88 |
0.0014 |
| 568 |
CEREBRAL HAEMORRHAGE |
51 |
0.0014 |
| 569 |
THERAPY PARTIAL RESPONDER |
22 |
0.0014 |
| 570 |
RENAL FAILURE |
187 |
0.0014 |
| 571 |
HAEMOGLOBIN ABNORMAL |
9 |
0.0014 |
| 572 |
LIVER INJURY |
34 |
0.0014 |
| 573 |
DELIRIUM |
48 |
0.0014 |
| 574 |
HYPOTHERMIA |
14 |
0.0014 |
| 575 |
HYPOCALCAEMIA |
26 |
0.0014 |
| 576 |
PETIT MAL EPILEPSY |
7 |
0.0014 |
| 577 |
RESPIRATORY DISORDER |
41 |
0.0014 |
| 578 |
HYPOVOLAEMIA |
8 |
0.0014 |
| 579 |
BLOOD CREATININE INCREASED |
89 |
0.0014 |
| 580 |
PNEUMONITIS |
37 |
0.0014 |
| 581 |
PETECHIAE |
14 |
0.0013 |
| 582 |
ODYNOPHAGIA |
8 |
0.0013 |
| 583 |
HAEMOLYTIC ANAEMIA |
12 |
0.0013 |
| 584 |
ANAEMIA |
255 |
0.0013 |
| 585 |
ECCHYMOSIS |
9 |
0.0013 |
| 586 |
ANAL FISTULA |
7 |
0.0013 |
| 587 |
FLUID OVERLOAD |
19 |
0.0013 |
| 588 |
ASPARTATE AMINOTRANSFERASE INCREASED |
69 |
0.0013 |
| 589 |
BEHAVIOUR DISORDER |
7 |
0.0013 |
| 590 |
ARTHRITIS INFECTIVE |
6 |
0.0013 |
| 591 |
WHITE BLOOD CELL COUNT DECREASED |
140 |
0.0013 |
| 592 |
CARDIAC ARREST |
106 |
0.0013 |
| 593 |
GASTROINTESTINAL INFLAMMATION |
10 |
0.0013 |
| 594 |
PULMONARY OEDEMA |
57 |
0.0013 |
| 595 |
FACE OEDEMA |
21 |
0.0012 |
| 596 |
ACUTE HEPATIC FAILURE |
17 |
0.0012 |
| 597 |
DISEASE RECURRENCE |
59 |
0.0012 |
| 598 |
RHINITIS |
10 |
0.0012 |
| 599 |
MAJOR DEPRESSION |
9 |
0.0012 |
| 600 |
HEPATITIS ACUTE |
8 |
0.0012 |
| 601 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
27 |
0.0012 |
| 602 |
HYPERCALCAEMIA |
15 |
0.0012 |
| 603 |
STEVENS-JOHNSON SYNDROME |
27 |
0.0012 |
| 604 |
LIVER FUNCTION TEST INCREASED |
26 |
0.0012 |
| 605 |
HEPATIC ENZYME INCREASED |
82 |
0.0012 |
| 606 |
PANCREATITIS ACUTE |
27 |
0.0012 |
| 607 |
RHABDOMYOLYSIS |
50 |
0.0012 |
| 608 |
GLUCOSE TOLERANCE IMPAIRED |
7 |
0.0012 |
| 609 |
HYPERGLYCAEMIA |
43 |
0.0012 |
| 610 |
HYPERTHERMIA |
9 |
0.0012 |
| 611 |
HEPATITIS |
30 |
0.0012 |
| 612 |
NEPHROTIC SYNDROME |
8 |
0.0012 |
| 613 |
SKIN HYPERPIGMENTATION |
10 |
0.0012 |
| 614 |
BLOOD MAGNESIUM DECREASED |
10 |
0.0012 |
| 615 |
METABOLIC ACIDOSIS |
37 |
0.0012 |
| 616 |
VENTRICULAR EXTRASYSTOLES |
12 |
0.0012 |
| 617 |
CONDITION AGGRAVATED |
350 |
0.0011 |
| 618 |
HAEMOGLOBIN DECREASED |
118 |
0.0011 |
| 619 |
MITRAL VALVE INCOMPETENCE |
13 |
0.0011 |
| 620 |
LUNG DISORDER |
56 |
0.0011 |
| 621 |
BLOOD UREA INCREASED |
19 |
0.0011 |
| 622 |
TASTE DISORDER |
23 |
0.0011 |
| 623 |
BRADYCARDIA |
60 |
0.0011 |
| 624 |
DRUG ERUPTION |
20 |
0.0011 |
| 625 |
ANAL FISSURE |
6 |
0.0011 |
| 626 |
CIRCULATORY COLLAPSE |
19 |
0.0011 |
| 627 |
TOXICITY TO VARIOUS AGENTS |
188 |
0.0011 |
| 628 |
TACHYCARDIA |
99 |
0.0011 |
| 629 |
OEDEMA |
60 |
0.0011 |
| 630 |
HAEMORRHOIDS |
21 |
0.0011 |
| 631 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
42 |
0.0011 |
| 632 |
BLOOD COUNT ABNORMAL |
16 |
0.0011 |
| 633 |
HYPERKALAEMIA |
37 |
0.0011 |
| 634 |
SKIN MASS |
7 |
0.0010 |
| 635 |
MOUTH ULCERATION |
22 |
0.0010 |
| 636 |
BRONCHIECTASIS |
7 |
0.0010 |
| 637 |
DIZZINESS POSTURAL |
10 |
0.0010 |
| 638 |
THERAPY NON-RESPONDER |
46 |
0.0010 |
| 639 |
VIRAL INFECTION |
34 |
0.0010 |
| 640 |
CARDIAC FAILURE CONGESTIVE |
82 |
0.0010 |
| 641 |
DRUG INEFFECTIVE |
1343 |
0.0010 |
| 642 |
JOINT EFFUSION |
7 |
0.0010 |
| 643 |
ATAXIA |
12 |
0.0010 |
| 644 |
PNEUMOTHORAX |
16 |
0.0010 |
| 645 |
TRICUSPID VALVE INCOMPETENCE |
8 |
0.0010 |
| 646 |
GINGIVAL PAIN |
8 |
0.0010 |
| 647 |
HEMIPARESIS |
17 |
0.0010 |
| 648 |
POLYNEUROPATHY |
12 |
0.0010 |
| 649 |
ANAL INCONTINENCE |
9 |
0.0010 |
| 650 |
MELAENA |
22 |
0.0010 |
| 651 |
BLOOD DISORDER |
8 |
0.0010 |
| 652 |
STATUS EPILEPTICUS |
11 |
0.0010 |
| 653 |
SCAB |
11 |
0.0010 |
| 654 |
APPENDICITIS |
9 |
0.0010 |
| 655 |
FAECES SOFT |
7 |
0.0010 |
| 656 |
LYMPHOCYTE COUNT DECREASED |
17 |
0.0010 |
| 657 |
PERICARDITIS |
16 |
0.0010 |
| 658 |
GINGIVAL BLEEDING |
13 |
0.0010 |
| 659 |
NEUROPATHY PERIPHERAL |
90 |
0.0009 |
| 660 |
GENERAL PHYSICAL HEALTH DETERIORATION |
109 |
0.0009 |
| 661 |
HAEMORRHAGE INTRACRANIAL |
14 |
0.0009 |
| 662 |
CHOLECYSTITIS |
11 |
0.0009 |
| 663 |
RENAL DISORDER |
43 |
0.0009 |
| 664 |
GASTROINTESTINAL HAEMORRHAGE |
77 |
0.0009 |
| 665 |
TROPONIN INCREASED |
7 |
0.0009 |
| 666 |
HALLUCINATION |
69 |
0.0009 |
| 667 |
URINE OUTPUT DECREASED |
8 |
0.0009 |
| 668 |
ATRIAL FIBRILLATION |
89 |
0.0009 |
| 669 |
ATRIOVENTRICULAR BLOCK |
7 |
0.0009 |
| 670 |
NO THERAPEUTIC RESPONSE |
11 |
0.0009 |
| 671 |
HAEMORRHAGE |
94 |
0.0009 |
| 672 |
SMALL INTESTINAL OBSTRUCTION |
11 |
0.0009 |
| 673 |
INTESTINAL PERFORATION |
10 |
0.0009 |
| 674 |
HYPOTENSION |
177 |
0.0009 |
| 675 |
DRUG INTOLERANCE |
85 |
0.0009 |
| 676 |
MYOCARDIAL ISCHAEMIA |
10 |
0.0009 |
| 677 |
INTERNAL HAEMORRHAGE |
10 |
0.0009 |
| 678 |
MUSCULAR WEAKNESS |
99 |
0.0009 |
| 679 |
NEOPLASM |
10 |
0.0009 |
| 680 |
MUSCLE ATROPHY |
11 |
0.0009 |
| 681 |
BLOOD POTASSIUM DECREASED |
26 |
0.0009 |
| 682 |
PRODUCT USE ISSUE |
162 |
0.0009 |
| 683 |
ORTHOSTATIC HYPOTENSION |
15 |
0.0009 |
| 684 |
HEPATIC ENCEPHALOPATHY |
8 |
0.0009 |
| 685 |
ABNORMAL FAECES |
7 |
0.0009 |
| 686 |
HIATUS HERNIA |
11 |
0.0008 |
| 687 |
LABORATORY TEST ABNORMAL |
25 |
0.0008 |
| 688 |
CARDIOGENIC SHOCK |
12 |
0.0008 |
| 689 |
SUPRAVENTRICULAR TACHYCARDIA |
8 |
0.0008 |
| 690 |
LIVER DISORDER |
37 |
0.0008 |
| 691 |
OSTEOMYELITIS |
15 |
0.0008 |
| 692 |
APHASIA |
25 |
0.0008 |
| 693 |
RENAL INJURY |
24 |
0.0008 |
| 694 |
PHARYNGITIS |
10 |
0.0008 |
| 695 |
EYELID PTOSIS |
8 |
0.0008 |
| 696 |
SUBARACHNOID HAEMORRHAGE |
8 |
0.0008 |
| 697 |
ISCHAEMIC STROKE |
14 |
0.0008 |
| 698 |
BODY TEMPERATURE INCREASED |
16 |
0.0008 |
| 699 |
SHOCK |
18 |
0.0008 |
| 700 |
SINUS TACHYCARDIA |
11 |
0.0008 |
| 701 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
13 |
0.0008 |
| 702 |
LACTIC ACIDOSIS |
25 |
0.0008 |
| 703 |
COVID-19 |
135 |
0.0008 |
| 704 |
HAEMATURIA |
26 |
0.0008 |
| 705 |
WHITE BLOOD CELL COUNT INCREASED |
29 |
0.0008 |
| 706 |
BLOOD PRESSURE ABNORMAL |
15 |
0.0008 |
| 707 |
CHILLS |
88 |
0.0007 |
| 708 |
NEOPLASM PROGRESSION |
26 |
0.0007 |
| 709 |
GASTRIC ULCER |
14 |
0.0007 |
| 710 |
PRODUCT PRESCRIBING ISSUE |
16 |
0.0007 |
| 711 |
OESOPHAGITIS |
8 |
0.0007 |
| 712 |
INTENTIONAL PRODUCT USE ISSUE |
64 |
0.0007 |
| 713 |
CONTRAINDICATED PRODUCT ADMINISTERED |
22 |
0.0007 |
| 714 |
CYSTITIS |
23 |
0.0007 |
| 715 |
URINARY TRACT INFECTION |
123 |
0.0007 |
| 716 |
BLOOD CALCIUM DECREASED |
8 |
0.0007 |
| 717 |
JAUNDICE |
19 |
0.0007 |
| 718 |
NERVOUS SYSTEM DISORDER |
22 |
0.0007 |
| 719 |
LOCALISED INFECTION |
17 |
0.0007 |
| 720 |
BRAIN INJURY |
7 |
0.0007 |
| 721 |
HEPATIC STEATOSIS |
13 |
0.0007 |
| 722 |
TUBULOINTERSTITIAL NEPHRITIS |
13 |
0.0007 |
| 723 |
SINUSITIS |
71 |
0.0007 |
| 724 |
ALTERED STATE OF CONSCIOUSNESS |
15 |
0.0007 |
| 725 |
EYELID OEDEMA |
8 |
0.0007 |
| 726 |
DEATH |
592 |
0.0007 |
| 727 |
TYPE 2 DIABETES MELLITUS |
23 |
0.0007 |
| 728 |
MALIGNANT MELANOMA |
9 |
0.0007 |
| 729 |
UPPER RESPIRATORY TRACT INFECTION |
31 |
0.0007 |
| 730 |
GASTROINTESTINAL DISORDER |
59 |
0.0007 |
| 731 |
SKIN ULCER |
17 |
0.0007 |
| 732 |
OSTEOPOROSIS |
27 |
0.0007 |
| 733 |
COMA |
31 |
0.0007 |
| 734 |
DECREASED APPETITE |
151 |
0.0006 |
| 735 |
OEDEMA PERIPHERAL |
79 |
0.0006 |
| 736 |
CARDIAC FAILURE |
52 |
0.0006 |
| 737 |
PULMONARY THROMBOSIS |
7 |
0.0006 |
| 738 |
EPISTAXIS |
48 |
0.0006 |
| 739 |
DRY EYE |
32 |
0.0006 |
| 740 |
DIARRHOEA |
403 |
0.0006 |
| 741 |
LYMPHADENOPATHY |
22 |
0.0006 |
| 742 |
HAEMATOMA |
16 |
0.0006 |
| 743 |
PRESYNCOPE |
15 |
0.0006 |
| 744 |
PRODUCT AVAILABILITY ISSUE |
14 |
0.0006 |
| 745 |
LETHARGY |
35 |
0.0006 |
| 746 |
DISORIENTATION |
24 |
0.0006 |
| 747 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
43 |
0.0006 |
| 748 |
INTERSTITIAL LUNG DISEASE |
29 |
0.0006 |
| 749 |
CONSTIPATION |
130 |
0.0006 |
| 750 |
HYPERTENSION |
126 |
0.0006 |
| 751 |
LOWER RESPIRATORY TRACT INFECTION |
27 |
0.0006 |
| 752 |
PULMONARY EMBOLISM |
56 |
0.0006 |
| 753 |
DRUG TOXICITY |
8 |
0.0006 |
| 754 |
OXYGEN SATURATION DECREASED |
33 |
0.0006 |
| 755 |
UNRESPONSIVE TO STIMULI |
15 |
0.0006 |
| 756 |
ASTHENIA |
217 |
0.0006 |
| 757 |
PULMONARY HYPERTENSION |
12 |
0.0006 |
| 758 |
ARRHYTHMIA |
27 |
0.0006 |
| 759 |
SKIN DISORDER |
19 |
0.0006 |
| 760 |
ABDOMINAL PAIN |
132 |
0.0006 |
| 761 |
DIALYSIS |
8 |
0.0006 |
| 762 |
PARALYSIS |
8 |
0.0006 |
| 763 |
SKIN CANCER |
12 |
0.0006 |
| 764 |
DRUG EFFECT INCOMPLETE |
20 |
0.0006 |
| 765 |
CARDIO-RESPIRATORY ARREST |
23 |
0.0005 |
| 766 |
SYNCOPE |
55 |
0.0005 |
| 767 |
VISUAL IMPAIRMENT |
68 |
0.0005 |
| 768 |
MYDRIASIS |
7 |
0.0005 |
| 769 |
GENITAL HAEMORRHAGE |
7 |
0.0005 |
| 770 |
SKIN HAEMORRHAGE |
8 |
0.0005 |
| 771 |
ORAL PAIN |
12 |
0.0005 |
| 772 |
SEIZURE |
61 |
0.0005 |
| 773 |
DERMATITIS CONTACT |
6 |
0.0005 |
| 774 |
PROTEINURIA |
10 |
0.0005 |
| 775 |
PRODUCTIVE COUGH |
25 |
0.0005 |
| 776 |
TENDONITIS |
8 |
0.0005 |
| 777 |
PALLOR |
14 |
0.0005 |
| 778 |
EOSINOPHILIA |
9 |
0.0005 |
| 779 |
HAEMATEMESIS |
13 |
0.0005 |
| 780 |
PANCREATITIS |
27 |
0.0005 |
| 781 |
PERIPHERAL COLDNESS |
7 |
0.0005 |
| 782 |
URINARY RETENTION |
17 |
0.0005 |
| 783 |
DIVERTICULITIS |
14 |
0.0005 |
| 784 |
SINUS DISORDER |
10 |
0.0005 |
| 785 |
DYSPNOEA EXERTIONAL |
19 |
0.0005 |
| 786 |
INFLAMMATION |
26 |
0.0005 |
| 787 |
BLOOD TEST ABNORMAL |
7 |
0.0005 |
| 788 |
BLINDNESS UNILATERAL |
7 |
0.0005 |
| 789 |
RENAL FAILURE ACUTE |
21 |
0.0005 |
| 790 |
STOMATITIS |
30 |
0.0005 |
| 791 |
NEURALGIA |
12 |
0.0005 |
| 792 |
CEREBRAL INFARCTION |
12 |
0.0005 |
| 793 |
BLINDNESS |
20 |
0.0005 |
| 794 |
BRONCHOSPASM |
7 |
0.0005 |
| 795 |
CONFUSIONAL STATE |
79 |
0.0005 |
| 796 |
GLOMERULAR FILTRATION RATE DECREASED |
6 |
0.0005 |
| 797 |
DEHYDRATION |
65 |
0.0005 |
| 798 |
CHROMATURIA |
11 |
0.0005 |
| 799 |
VOMITING |
229 |
0.0005 |
| 800 |
MYALGIA |
82 |
0.0005 |
| 801 |
GASTROENTERITIS |
7 |
0.0005 |
| 802 |
PHOTOPHOBIA |
9 |
0.0005 |
| 803 |
BONE PAIN |
28 |
0.0005 |
| 804 |
NAUSEA |
371 |
0.0005 |
| 805 |
POST PROCEDURAL COMPLICATION |
9 |
0.0005 |
| 806 |
COUGH |
130 |
0.0005 |
| 807 |
HOSPITALISATION |
71 |
0.0005 |
| 808 |
PLASMA CELL MYELOMA |
18 |
0.0005 |
| 809 |
RASH ERYTHEMATOUS |
22 |
0.0005 |
| 810 |
CATARACT |
27 |
0.0005 |
| 811 |
MUSCULOSKELETAL CHEST PAIN |
7 |
0.0005 |
| 812 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
13 |
0.0004 |
| 813 |
AGEUSIA |
11 |
0.0004 |
| 814 |
ACUTE MYOCARDIAL INFARCTION |
13 |
0.0004 |
| 815 |
HALLUCINATION, AUDITORY |
7 |
0.0004 |
| 816 |
RIB FRACTURE |
9 |
0.0004 |
| 817 |
RESPIRATORY ARREST |
12 |
0.0004 |
| 818 |
BLOOD POTASSIUM INCREASED |
7 |
0.0004 |
| 819 |
DEEP VEIN THROMBOSIS |
28 |
0.0004 |
| 820 |
INFLUENZA |
48 |
0.0004 |
| 821 |
DERMATITIS |
9 |
0.0004 |
| 822 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
10 |
0.0004 |
| 823 |
CHOLELITHIASIS |
14 |
0.0004 |
| 824 |
DYSPNOEA |
240 |
0.0004 |
| 825 |
GENERALISED TONIC-CLONIC SEIZURE |
7 |
0.0004 |
| 826 |
FATIGUE |
329 |
0.0004 |
| 827 |
RETCHING |
9 |
0.0004 |
| 828 |
ANGINA PECTORIS |
12 |
0.0004 |
| 829 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
12 |
0.0004 |
| 830 |
SKIN EXFOLIATION |
35 |
0.0004 |
| 831 |
SOMNOLENCE |
83 |
0.0004 |
| 832 |
APATHY |
6 |
0.0004 |
| 833 |
THROMBOSIS |
33 |
0.0004 |
| 834 |
MENORRHAGIA |
8 |
0.0004 |
| 835 |
COGNITIVE DISORDER |
19 |
0.0004 |
| 836 |
NIGHT SWEATS |
13 |
0.0004 |
| 837 |
TREATMENT NONCOMPLIANCE |
22 |
0.0004 |
| 838 |
MUSCULOSKELETAL PAIN |
21 |
0.0004 |
| 839 |
PNEUMONIA ASPIRATION |
10 |
0.0004 |
| 840 |
TREMOR |
66 |
0.0004 |
| 841 |
ALOPECIA |
78 |
0.0004 |
| 842 |
THERAPEUTIC RESPONSE DECREASED |
24 |
0.0004 |
| 843 |
EPILEPSY |
12 |
0.0004 |
| 844 |
CHEST DISCOMFORT |
40 |
0.0004 |
| 845 |
FEMUR FRACTURE |
12 |
0.0004 |
| 846 |
ABDOMINAL DISTENSION |
40 |
0.0004 |
| 847 |
DEAFNESS |
10 |
0.0004 |
| 848 |
AGITATION |
28 |
0.0004 |
| 849 |
MALIGNANT NEOPLASM PROGRESSION |
39 |
0.0004 |
| 850 |
PRODUCT PRESCRIBING ERROR |
9 |
0.0004 |
| 851 |
MOBILITY DECREASED |
27 |
0.0004 |
| 852 |
BLOOD SODIUM DECREASED |
7 |
0.0004 |
| 853 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
8 |
0.0004 |
| 854 |
MUSCULOSKELETAL DISORDER |
7 |
0.0004 |
| 855 |
CHEST PAIN |
67 |
0.0004 |
| 856 |
EAR PAIN |
7 |
0.0004 |
| 857 |
WEIGHT DECREASED |
100 |
0.0004 |
| 858 |
CARDIOVASCULAR DISORDER |
9 |
0.0004 |
| 859 |
CONTUSION |
34 |
0.0004 |
| 860 |
PRODUCT DOSE OMISSION IN ERROR |
10 |
0.0004 |
| 861 |
FEEDING DISORDER |
7 |
0.0003 |
| 862 |
RASH |
150 |
0.0003 |
| 863 |
RASH MACULAR |
12 |
0.0003 |
| 864 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 865 |
IMPAIRED HEALING |
11 |
0.0003 |
| 866 |
HEADACHE |
210 |
0.0003 |
| 867 |
GOUT |
6 |
0.0003 |
| 868 |
CONVULSION |
19 |
0.0003 |
| 869 |
RASH PRURITIC |
18 |
0.0003 |
| 870 |
PERIPHERAL SWELLING |
51 |
0.0003 |
| 871 |
LOSS OF CONSCIOUSNESS |
42 |
0.0003 |
| 872 |
FAECES DISCOLOURED |
7 |
0.0003 |
| 873 |
EYE SWELLING |
12 |
0.0003 |
| 874 |
SWELLING FACE |
21 |
0.0003 |
| 875 |
MENTAL DISORDER |
14 |
0.0003 |
| 876 |
PRODUCT DISPENSING ERROR |
7 |
0.0003 |
| 877 |
EYE PAIN |
18 |
0.0003 |
| 878 |
HEAD INJURY |
10 |
0.0003 |
| 879 |
GLAUCOMA |
6 |
0.0003 |
| 880 |
DRY MOUTH |
25 |
0.0003 |
| 881 |
DIPLOPIA |
8 |
0.0003 |
| 882 |
DYSPHAGIA |
29 |
0.0003 |
| 883 |
GASTRITIS |
8 |
0.0003 |
| 884 |
BLISTER |
17 |
0.0003 |
| 885 |
INFUSION RELATED REACTION |
20 |
0.0003 |
| 886 |
DIABETES MELLITUS |
23 |
0.0003 |
| 887 |
ERYTHEMA |
62 |
0.0003 |
| 888 |
BACK PAIN |
70 |
0.0003 |
| 889 |
VISUAL ACUITY REDUCED |
10 |
0.0003 |
| 890 |
HERPES ZOSTER |
17 |
0.0003 |
| 891 |
BLOOD PRESSURE FLUCTUATION |
7 |
0.0003 |
| 892 |
VISION BLURRED |
40 |
0.0003 |
| 893 |
UNEVALUABLE EVENT |
22 |
0.0003 |
| 894 |
FALL |
95 |
0.0003 |
| 895 |
PAIN IN JAW |
8 |
0.0003 |
| 896 |
FLUID RETENTION |
14 |
0.0003 |
| 897 |
OSTEONECROSIS |
9 |
0.0003 |
| 898 |
HAEMATOCHEZIA |
15 |
0.0003 |
| 899 |
ADVERSE EVENT |
25 |
0.0003 |
| 900 |
PSYCHOTIC DISORDER |
8 |
0.0003 |
| 901 |
URINARY INCONTINENCE |
8 |
0.0003 |
| 902 |
ECZEMA |
14 |
0.0003 |
| 903 |
ADVERSE DRUG REACTION |
24 |
0.0003 |
| 904 |
SWELLING |
25 |
0.0003 |
| 905 |
UNDERDOSE |
19 |
0.0003 |
| 906 |
OROPHARYNGEAL PAIN |
24 |
0.0003 |
| 907 |
ABDOMINAL DISCOMFORT |
43 |
0.0003 |
| 908 |
PRODUCT DOSE OMISSION ISSUE |
75 |
0.0003 |
| 909 |
ILLNESS |
26 |
0.0003 |
| 910 |
GAIT DISTURBANCE |
48 |
0.0003 |
| 911 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
45 |
0.0002 |
| 912 |
ANGIOEDEMA |
11 |
0.0002 |
| 913 |
DIZZINESS |
124 |
0.0002 |
| 914 |
CARDIAC DISORDER |
23 |
0.0002 |
| 915 |
INTERNATIONAL NORMALISED RATIO INCREASED |
7 |
0.0002 |
| 916 |
DYSURIA |
9 |
0.0002 |
| 917 |
EYE DISORDER |
8 |
0.0002 |
| 918 |
BALANCE DISORDER |
21 |
0.0002 |
| 919 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
49 |
0.0002 |
| 920 |
TINNITUS |
11 |
0.0002 |
| 921 |
SKIN DISCOLOURATION |
11 |
0.0002 |
| 922 |
GASTROOESOPHAGEAL REFLUX DISEASE |
19 |
0.0002 |
| 923 |
ANAPHYLACTIC REACTION |
13 |
0.0002 |
| 924 |
RECTAL HAEMORRHAGE |
10 |
0.0002 |
| 925 |
CORONARY ARTERY DISEASE |
7 |
0.0002 |
| 926 |
BLOOD PRESSURE DECREASED |
15 |
0.0002 |
| 927 |
DISTURBANCE IN ATTENTION |
12 |
0.0002 |
| 928 |
FREQUENT BOWEL MOVEMENTS |
6 |
0.0002 |
| 929 |
HEART RATE INCREASED |
22 |
0.0002 |
| 930 |
WHEEZING |
13 |
0.0002 |
| 931 |
RHINORRHOEA |
14 |
0.0002 |
| 932 |
AMNESIA |
14 |
0.0002 |
| 933 |
DYSARTHRIA |
8 |
0.0002 |
| 934 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 935 |
HYPOGLYCAEMIA |
10 |
0.0002 |
| 936 |
DYSPHONIA |
12 |
0.0002 |
| 937 |
BRONCHITIS |
15 |
0.0002 |
| 938 |
COLITIS ULCERATIVE |
9 |
0.0002 |
| 939 |
WEIGHT INCREASED |
45 |
0.0002 |
| 940 |
NEOPLASM MALIGNANT |
13 |
0.0002 |
| 941 |
HYPOAESTHESIA |
29 |
0.0002 |
| 942 |
BONE DENSITY DECREASED |
6 |
0.0002 |
| 943 |
JOINT SWELLING |
23 |
0.0002 |
| 944 |
PAIN IN EXTREMITY |
56 |
0.0002 |
| 945 |
ABDOMINAL PAIN UPPER |
39 |
0.0002 |
| 946 |
MALAISE |
83 |
0.0002 |
| 947 |
DYSGEUSIA |
14 |
0.0002 |
| 948 |
DRY SKIN |
25 |
0.0002 |
| 949 |
HIP FRACTURE |
6 |
0.0002 |
| 950 |
PARAESTHESIA |
29 |
0.0002 |
| 951 |
PAIN |
113 |
0.0002 |
| 952 |
ARTHRALGIA |
76 |
0.0002 |
| 953 |
EYE PRURITUS |
6 |
0.0002 |
| 954 |
FLATULENCE |
10 |
0.0002 |
| 955 |
INCORRECT DOSE ADMINISTERED |
40 |
0.0002 |
| 956 |
PRURITUS |
67 |
0.0002 |
| 957 |
DYSPEPSIA |
17 |
0.0002 |
| 958 |
ACNE |
13 |
0.0002 |
| 959 |
MUSCULOSKELETAL STIFFNESS |
15 |
0.0002 |
| 960 |
CHRONIC KIDNEY DISEASE |
13 |
0.0002 |
| 961 |
MUSCLE SPASMS |
31 |
0.0002 |
| 962 |
THERAPY INTERRUPTED |
12 |
0.0002 |
| 963 |
POLLAKIURIA |
7 |
0.0002 |
| 964 |
OVERDOSE |
36 |
0.0002 |
| 965 |
ILL-DEFINED DISORDER |
10 |
0.0002 |
| 966 |
VERTIGO |
10 |
0.0002 |
| 967 |
HYPOACUSIS |
7 |
0.0002 |
| 968 |
NECK PAIN |
9 |
0.0002 |
| 969 |
INSOMNIA |
42 |
0.0002 |
| 970 |
FLUSHING |
16 |
0.0002 |
| 971 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
8 |
0.0002 |
| 972 |
MEMORY IMPAIRMENT |
21 |
0.0002 |
| 973 |
DEPRESSED MOOD |
8 |
0.0002 |
| 974 |
ANXIETY |
42 |
0.0001 |
| 975 |
SUICIDAL IDEATION |
13 |
0.0001 |
| 976 |
SLEEP DISORDER |
10 |
0.0001 |
| 977 |
BLOOD PRESSURE INCREASED |
21 |
0.0001 |
| 978 |
INTENTIONAL PRODUCT MISUSE |
12 |
0.0001 |
| 979 |
PALPITATIONS |
16 |
0.0001 |
| 980 |
BLOOD GLUCOSE INCREASED |
25 |
0.0001 |
| 981 |
MYOCARDIAL INFARCTION |
23 |
0.0001 |
| 982 |
DISCOMFORT |
8 |
0.0001 |
| 983 |
ARTHROPATHY |
7 |
0.0001 |
| 984 |
INFLUENZA LIKE ILLNESS |
10 |
0.0001 |
| 985 |
NASOPHARYNGITIS |
22 |
0.0001 |
| 986 |
HYPERSENSITIVITY |
22 |
0.0001 |
| 987 |
ASTHMA |
13 |
0.0001 |
| 988 |
FEELING HOT |
7 |
0.0001 |
| 989 |
URTICARIA |
17 |
0.0001 |
| 990 |
CEREBROVASCULAR ACCIDENT |
16 |
0.0001 |
| 991 |
FEELING ABNORMAL |
20 |
0.0001 |
| 992 |
NO ADVERSE EVENT |
15 |
0.0001 |
| 993 |
HYPERHIDROSIS |
10 |
0.0001 |
| 994 |
ARTHRITIS |
6 |
0.0001 |
| 995 |
DEPRESSION |
16 |
0.0001 |